Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 161

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 161
---
 2023 and 7 outstanding as         
 of September 30,2022                                                                                                                  |     |                      |                        2 |   |     |     |           - |   |     |          |                        2 |   |
| Additional Paid in capital                                                                                                            |     |                      |               14,684,216 |   |     |     |     (17,492 | ) |     |          |               14,666,724 |   |
| Contributed Capital                                                                                                                   |     |                      |                  736,326 |   |     |     |           - |   |     |          |                  736,326 |   |
| Accumulated Other Comprehensive Income                                                                                                |     |                      |                        - |   |     |     |    (204,847 | ) |     |          |                 (204,847 | ) |
| Retained Earnings (Deficit)                                                                                                           |     |                      |              (20,616,114 | ) |     |     |      (5,851 | ) |     |          |              (20,417,118 | ) |
| Total Stockholders’ Equity (Deficit)                                                                                                  |     |                      |               (5,194,030 | ) |     |     |    (228,191 | ) |     |          |               (5,217,373 | ) |
| TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)                                                                                    |     | $                    |                  177,611 |   |     |     |    (221,374 | ) |     | $        |                  161,084 |   |

<div align='center'>121</div>

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth information known to the Company with respect to the beneficial ownership of each class of the Company’s capital stock as of November 10, 2025 for (1) each person known by the Company to beneficially own more than 10% of each class of the Company’s voting securities, (2) each executive officer, (3) each of the Company’s directors and (4) all of the Company’s executive officers and directors as a group.

Based on 108,054,704 shares issued and outstanding

| Title of Class |     | Name and Address of Beneficial Owner              |     | Amount and 
 Nature of  
 Beneficial 
 Ownership  |            |   |     | Percentage |